Skip to Content
Merck
HomeServicesContract ManufacturingCell & Virus Banking and StorageVirus Bank Manufacturing

Virus Bank Manufacturing

Virus Bank Manufacturing

A virus bank is a vital part of manufacturing. Choosing a partner with expertise ensures high-quality banks are used in the development of your vaccines and recombinant proteins. At our cGMP facility in Glasgow, Scotland, we excel at producing master virus seed stocks (MVSS), as well as subsequent production of working virus seed stocks (WVSS).

As your one-stop partner, our testing ensures that your bank is:

  • Free of contamination
  • Replication-competent (high titer)
  • Compliant with your requirements for identity, purity, and stability

We can also store your virus banks at our facilities in the U.K., U.S., and Singapore, utilizing a strict inventory control system that protects against cross-contamination.

To learn more or request a quote, use our reply form to see how our virus bank manufacturing capabilities can meet your project needs.

Request Information

Related Services
Biorepository & Storage
Store your precious material in GMP-compliant facilities amongst three continents. A range of materials including virus and cell banks can be stored in ambient, liquid nitrogen or –80 conditions.
Bulk Harvest Release Testing
Whether you’re preparing for first-in-human clinical trials or scaling up for global distribution of a life-changing therapeutic biologic, our cGMP-compliant bulk harvest release testing services protect your investment at every step.
Final Product Release Testing
With all biologics released into global pharmaceutical markets requiring GMP testing of final product, we offer a wide range of assays and lot release testing services to help you demonstrate compliance with regulatory guidelines.
Related Applications
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?